Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ICOSLG Antikörper (Extracellular Domain)

ICOSLG Reaktivität: Human FACS, cELISA Wirt: Maus Monoclonal GM-13C1 unconjugated
Produktnummer ABIN108723
  • Target Alle ICOSLG Antikörper anzeigen
    ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
    Bindungsspezifität
    • 8
    • 7
    • 7
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Extracellular Domain
    Reaktivität
    • 71
    • 13
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 44
    • 28
    • 6
    • 1
    Maus
    Klonalität
    • 40
    • 38
    • 1
    Monoklonal
    Konjugat
    • 48
    • 8
    • 8
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser ICOSLG Antikörper ist unkonjugiert
    Applikation
    • 45
    • 36
    • 26
    • 16
    • 6
    • 6
    • 5
    • 5
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Cell-ELISA (cELISA)
    Spezifität
    GM13C1 recognises the extracellular domain of ICOSL transiently expressed on the cell surface of transfected BOSC cells as well as the native protein on antigen presenting cells (see reference).
    Aufreinigung
    Protein G
    Immunogen
    genetic immunisation with cDNA encoding human ICOSL (extracellular domain)
    Klon
    GM-13C1
    Isotyp
    IgG1
    Top Product
    Discover our top product ICOSLG Primärantikörper
  • Applikationshinweise
    Flow cytometry: 1.2 µg/10^6 cells
    CELISA: 1:200 - 1:400
    For each application a titration should be performed to determine the optimal concentration.
    Kommentare

    Synonyms: ICOS ligand

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Buffer
    PBS, pH 7.2
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C
    Informationen zur Lagerung
    short term: 2 °C - 8 °C, long term: -20 °C
  • Target
    ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
    Andere Bezeichnung
    ICOSL (ICOSLG Produkte)
    Synonyme
    ICOSLG antikoerper, AU044799 antikoerper, B7-H2 antikoerper, B7RP-1 antikoerper, B7h antikoerper, BG071784 antikoerper, GI50 antikoerper, GL50 antikoerper, GL50-B antikoerper, ICOS-L antikoerper, Icoslg antikoerper, LICOS antikoerper, Ly115l antikoerper, mKIAA0653 antikoerper, B7H2 antikoerper, B7RP1 antikoerper, CD275 antikoerper, ICOSL antikoerper, Icosl antikoerper, RGD1562791 antikoerper, inducible T-cell costimulator ligand antikoerper, icos ligand antikoerper, inducible T-cell co-stimulator ligand antikoerper, ICOSLG antikoerper, Icosl antikoerper, Icoslg antikoerper
    Hintergrund
    The inducible co-stimulator receptor (ICOS) is a member of the CD28 receptor family that is expressed on T cells. ICOS ligand (ICOSL) has been identified as a ligand that binds to ICOS, but not to CD28 or CTLA4. GM13C1 was generated by genetic immunisation and recognises the extracellular domain of ICOSL.
    UniProt
    O75144
    Pathways
    Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
Sie sind hier:
Kundenservice